# OnCo record stingray-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/stingray-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "stingray-therapeutics" ;
  schema:name "Stingray Therapeutics"@en ;
  schema:alternateName "Stingray Therapeutics, Inc."@en ;
  schema:description "Stingray Therapeutics is a Houston company developing vizenpistat, a tablet designed to switch back on an early-warning part of the immune system that many tumours turn off. It is being tested with two immunotherapy antibodies in bowel cancer that is microsatellite stable."@en ;
  schema:url <https://onco.cc/companies/stingray-therapeutics/>, <https://www.stingraytx.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.stingraytx.com/>, <https://reporter.nih.gov/project-details/11393170>, <https://clinicaltrials.gov/study/NCT06063681> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/vizenpistat/> ;
  onco:trials <https://onco.cc/trials/nct06589440/> .